Andras Illes, MD, PhD

Fresenius Kabi SwissBioSim
Eysin, Switzerland

Andras Illes MD, PhD is a clinical development lead at Fresenius Kabi SwissBioSim with 15 years of experience in the field of clinical development. In the past 15 years Andras worked with biosimilars in various therapeutic fields such as rheumatology and oncology.

Presentation(s):

• 0445: Comparison of the Efficacy, Safety and Immunogenicity of a Proposed Biosimilar MSB11456 with Tocilizumab Reference Product in Moderate-to-severe Rheumatoid Arthritis: Results of a Randomized Double-blind Study

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.